What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

書誌詳細
主要な著者:	Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
フォーマット:	Journal article
言語:	English
出版事項:	Journal of Rheumatology 2018

類似資料

What should be the primary target of ‘treat to target’ in PsA?
著者:: Coates, L, 等
出版事項: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
著者:: Coates, L, 等
出版事項: (2022)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
著者:: Coates, L, 等
出版事項: (2019)

Sustained very low disease activity and remission in psoriatic arthritis patients
著者:: Lubrano, E, 等
出版事項: (2019)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
著者:: Lubrano E, 等
出版事項: (2016-10-01)

New approved drugs for psoriatic arthritis
著者:: F.M. Perrotta, 等
出版事項: (2016-09-01)

Precision medicine in psoriatic arthritis: how should we select targeted therapies?
著者:: Al-Mossawi, H, 等
出版事項: (2019)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
著者:: Ennio Lubrano, 等
出版事項: (2019-08-01)

How should we define disease and outcomes in axial psoriatic arthritis?
著者:: Coates, LC
出版事項: (2021)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
著者:: Ennio Lubrano, 等
出版事項: (2023-07-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
著者:: P.S. Helliwell
出版事項: (2011-09-01)

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
著者:: Coates, L, 等
出版事項: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
著者:: Coates, L, 等
出版事項: (2016)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
著者:: Weinstein, SM, 等
出版事項: (2021)

Novel concepts in psoriatic arthritis management: Can we treat to target?
著者:: Tucker, L, 等
出版事項: (2018)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
著者:: Dures, E, 等
出版事項: (2020)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
著者:: Ye, W, 等
出版事項: (2021)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
著者:: Gladman, DD, 等
出版事項: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
著者:: Helliwell, PS, 等
出版事項: (2023)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
著者:: Perrotta, FM, 等
出版事項: (2024)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
著者:: Ye, W, 等
出版事項: (2021)

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
著者:: F.M. Perrotta, 等
出版事項: (2019-07-01)

Current concepts and unmet needs in psoriatic arthritis
著者:: Mahmood, F, 等
出版事項: (2017)

Psoriatic arthritis: prospects for the future
著者:: Hackett, S, 等
出版事項: (2022)

Should methotrexate have any place in the treatment of psoriatic arthritis?
著者:: Ye, W, 等
出版事項: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
著者:: Helliwell, PS, 等
出版事項: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
著者:: Coates, L, 等
出版事項: (2016)

Measuring outcomes in psoriatic arthritis
著者:: Ogdie, A, 等
出版事項: (2020)

Outcome measures in psoriatic arthritis: where next?
著者:: Hackett, S, 等
出版事項: (2022)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
著者:: Ennio Lubrano, 等
出版事項: (2022-12-01)

Psoriatic arthritis: lessons from imaging studies and implications for therapy
著者:: Mathew, A, 等
出版事項: (2016)

Assessing disease activity in psoriatic arthritis: a literature review
著者:: Tucker, L, 等
出版事項: (2018)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
著者:: Mease, PJ, 等
出版事項: (2020)

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
著者:: Helliwell, P, 等
出版事項: (2019)

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial
著者:: O'Dwyer, J, 等
出版事項: (2018)

Remission in psoriatic arthritis—where are we now?
著者:: Coates, L, 等
出版事項: (2017)

Identification of psoriatic arthritis in patients with psoriasis
著者:: Coates, LC, 等
出版事項: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
著者:: Soriano, ER, 等
出版事項: (2023)

Psoriatic arthritis: imaging techniques
著者:: E. Lubrano, 等
出版事項: (2012-06-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
著者:: Coates, L, 等
出版事項: (2018)